Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, August 04, 2021
DisperSol Technologies, a clinical-stage pharmaceutical company developing new treatments for oncology and rare diseases, and Catalent, a global provider of advanced delivery technologies...
read more
Wednesday, August 04, 2021
Evonik has acquired German biotech company JeNaCell. The acquisition expands Evonik’s biomaterials portfolio to provide biotechnologically derived cellulose. The nature-identical material developed by JeNaCell is used in medical technology and ...
read more
Wednesday, August 04, 2021
Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization (CDMO) will include Daikyo Crystal Zenith® (CZ) container-closure components, offered by West Pharmaceutical Services, Inc. (West), as part of its aseptic ...
read more
Wednesday, August 04, 2021
Nanoform, an innovative nanoparticle medicine enabling company, announces that Proof of Concept studies may now be performed for Boehringer Ingelheim to assess the added value Nanoform’s award-winning CESS® technology can deliver to its drug ...
read more
Omnicell, Inc., a leading provider of medication management solutions and adherence tools for health systems and pharmacies, announced a definitive agreement with pharmacy software solutions provider FDS Amplicare to acquire its business for total ...
read more
Centogene N.V., a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, announced the appointment of Dr. Patrice P. Denèfle as Chief Scientific Officer (CSO). Dr. Denèfle will join ...
read more
Catalent’s OptiDose Design Solution, led by Catalent’s scientific advisors, uses a design approach that combines data-driven scientific tools with Catalent’s extensive development expertise. Integrating pharmaceutics, and dose form design target ...
read more
Genezen Laboratories Inc. a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has further strengthened its senior leadership team with the appointment of Brok Weichbrodt as Vice President of Operations.
read more
Rho, a full-service contract research organization (CRO), announced its Human Epidemiology and Response to SARS-CoV-2 (HEROS) study, to help determine the rate of the new coronavirus infection in children and their families in the U.S. has been ...
read more
BioStem Technologies Inc., a pre-clinical-stage biotechnology company focused on elements of perinatal tissue for use in regenerative therapies; announced that it has engaged Biologics Consulting, a full-service regulatory and product development ...
read more
Metrion Biosciences Limited, the specialist ion channel contract research and drug discovery company, announced the appointment of Nick Foster as Chief Commercial Officer and Head of Global Business Development, to support the broadening of Metrion’s...
read more
10x Genomics Inc. announced that it has entered into a global settlement and cross-license agreement with Bio-Rad Laboratories Inc.. The agreement grants each company a non-exclusive, worldwide, royalty-bearing license to develop products and ...
read more
NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. Findings from this research are vital to NIAID’s efforts to advance vaccines, drugs, and ...
read more
Element Materials Technology has acquired Arch Sciences Group, a leading provider of analytical services and laboratory solutions in pharmaceuticals. As well as marking Element’s entry into the European pharmaceutical market, the move means that the ...
read more
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it will commence the first phase of a ...
read more